Stay updated on LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial

Sign up to get notified when there's something new on the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:22:38.000Z thumbnail image
  3. Check
    29 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:51:12.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T08:29:13.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T22:11:26.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T17:41:16.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The study has completed both the Phase 1 and Phase 2a portions, with updates indicating successful administration of LASN01 in patients with IPF and PF-ILD, while previous recruitment statuses and estimated future locations have been removed.
    Difference
    4%
    Check dated 2025-01-05T14:08:11.000Z thumbnail image

Stay in the know with updates to LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page.